Inclusion Criteria:

1. Male or female patients > 35 years and <=55 years of age.

2. confirmed case (patients with HCC)

3. Tumors can be radical removed and resection volume was 50% to 70%.

4. Criteria of liver function: Child A level, serum bilirubin ≤ 1.5 times the upper
limit of normal value,alanine aminotransferase and aspartate aminotransferase ≤ 2
times the upper limit of normal value.

5. No dysfunction in major organs; Blood routine, kidney function, cardiac function and
lung function are basically normal. Hbg ≥ 90g/L, WBC ≥ 3.000 cells/mm³,platelets ≥
80.000 cells/mm³.

6. Karnofsky Performance Score performance over 60.

7. Patients who can understand this trial and have signed information consent.

Exclusion Criteria:

1. Patients who have undergone previous treatment by Ulinastatin.

2. Patients with apparent cardiac, pulmonary, cerebronic and renal dysfunction, which
may affect the treatment of liver cancer.

3. Patients with other diseases which may affect the treatment mentioned here.

4. Patients with medical history of other malignant tumors.

5. Subjects participating in other clinical trials.

6. Extrahepatic metastasis, portal vein or other major vascular involvement. liver
function: Child B C.

7. Patients would not sign the consent to the trial.